Gene therapy shows promise in the management of inherited peripheral neuropathy and the complex array of symptoms that patients experience. Gene therapy holds promise in the management of peripheral neuropathies and in significant improvement of quality of life for patients.
Younger age at onset of type 2 diabetes is associated with an increased risk for subsequent dementia later in life.
Specific vascular disease risk factors may be linked to disease progression and decreased brain phosphate metabolism in patients with multiple sclerosis.
Because current treatment options are not effective for many patients with painful diabetic neuropathy, investigators evaluated the impact of spinal cord stimulation on those with this progressive chronic pain condition.
Study researchers presented their findings regarding race differences in 10-year mortality following ischemic stroke during the 2021 International Stroke Conference.
Type 2 diabetes mellitus is associated with an increased risk for Parkinson disease (PD), as well as more rapid PD progression.
A team of researchers assessed mortality and neurologic outcomes in patients with lumbosacral radiculoplexus neuropathy.
A study looks at the root cause of corneal pain in these patients.
The researchers investigated how axonal swellings in cutaneous nerve fibers are related to T2D mellitus and distal diabetic sensorimotor polyneuropathy in patents with T2D.
Can nonviral gene delivery of hepatocyte growth factor reduce pain in patients with DPN and modify progression of the disorder?
